Literature DB >> 29098882

pH- and thermo-sensitive MTX-loaded magnetic nanocomposites: synthesis, characterization, and in vitro studies on A549 lung cancer cell and MR imaging.

Masoud Farshbaf1,2,3, Roya Salehi2, Nasim Annabi4,5,6, Rovshan Khalilov7,8, Abolfazl Akbarzadeh3,9,10, Soodabeh Davaran11.   

Abstract

In the current study, we proposed a facile method for fabrication of multifunctional pH- and thermo-sensitive magnetic nanocomposites (MNCs) as a theranostic agent for using in targeted drug delivery and magnetic resonance imaging (MRI). To this end, we decorated Fe3O4 magnetic nanoparticles (MNPs) with N,N-dimethylaminoethyl methacrylate (DMAEMA) and N-isopropylacrylamide (NIPAAm), best known for their pH- and thermo-sensitive properties, respectively. We also conjugated mesoporous silica nanoparticles (MSNs) to polymer matrix acting as drug container to enhance the drug encapsulation efficacy. Methotroxate (MTX) as a model drug was successfully loaded in MNCs (M-MNCs) via surface adsorption onto MSNs and electrostatic interaction between drug and carrier. The pH- and temperature-triggered release of MTX was concluded through the evaluation of in vitro release at both physiological and simulated tumor tissue conditions. Based on in vitro cytotoxicity assay results, M-MNCs significantly revealed higher antitumor activity compared to free MTX. In vitro MR susceptibility experiment showed that M-MNCs relatively possessed high transverse relaxivity (r2) of about 0.15 mM-1·ms-1 and a linear relationship between the transverse relaxation rate (R2) and the Fe concentration in the M-MNCs was also demonstrated. Therefore, the designed MNCs can potentially become smart drug carrier, while they also can be promising MRI negative contrast agent.

Entities:  

Keywords:  MRI contrast agent; Theranostic nanomedicine; dual-responsive drug delivery; lung cancer; magnetic nanoparticles; methotrexate

Mesh:

Substances:

Year:  2017        PMID: 29098882     DOI: 10.1080/03639045.2017.1397686

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  8 in total

1.  Synthesis and characterisation of iron oxide nanoparticles conjugated with epidermal growth factor receptor (EGFR) monoclonal antibody as MRI contrast agent for cancer detection.

Authors:  Zeinab Salehnia; Daryoush Shahbazi-Gahrouei; Abolfazl Akbarzadeh; Behzad Baradaran; Safar Farajnia; Mehran Naghibi
Journal:  IET Nanobiotechnol       Date:  2019-06       Impact factor: 1.847

2.  A Lysine-Functionalized Graphene Oxide-Based Nanoplatform for Delivery of Fluorouracil to A549 Human Lung Cancer Cells: A Comparative Study.

Authors:  Maryam Ashjaran; Mirzaagha Babazadeh; Abolfazl Akbarzadeh; Soodabeh Davaran; Roya Salehi
Journal:  Tanaffos       Date:  2021-04

Review 3.  Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy.

Authors:  Theodora Amanda Seidu; Perpetua Takunda Kutoka; Dorothy Owusu Asante; Muhammad Asim Farooq; Raphael N Alolga; Wang Bo
Journal:  Pharmaceutics       Date:  2022-05-23       Impact factor: 6.525

4.  Needle-shaped amphoteric calix[4]arene as a magnetic nanocarrier for simultaneous delivery of anticancer drugs to the breast cancer cells.

Authors:  Mahdi Rahimi; Ramin Karimian; Ehsan Bahojb Noruzi; Khudaverdi Ganbarov; Mojtaba Zarei; Fadhil S Kamounah; Bahman Yousefi; Milad Bastami; Mehdi Yousefi; Hossein Samadi Kafil
Journal:  Int J Nanomedicine       Date:  2019-04-15

5.  Effects of self-assembled cell-penetrating peptides and their nano-complexes on ABCB1 expression and activity.

Authors:  Mehri Niazi; Parvin Zakeri-Milani; Mehdi Soleymani-Goloujeh; Ali Mohammadi; Muhammad Sarfraz; Raimar Löbenberg; Saeedeh Najafi-Hajivar; Javid Shahbazi-Mojarrad; Masoud Farshbaf; Hadi Valizadeh
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699

6.  Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery.

Authors:  Parvin Zakeri-Milani; Saeedeh Najafi-Hajivar; Muhammad Sarfraz; Ali Nokhodchi; Hamed Mohammadi; Soheila Montazersaheb; Mehri Niazi; Maryam Hemmatzadeh; Mehdi Soleymani-Goloujeh; Behzad Baradaran; Javid Shahbazi Mojarrad; Masoud Farshbaf; Tooba Gholikhani; Hadi Valizadeh
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

Review 7.  Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform.

Authors:  Fengzhi Cui; Jianhua Liu; Siwen Pang; Bo Li
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 8.  Physically stimulus-responsive nanoparticles for therapy and diagnosis.

Authors:  Fatemeh Farjadian; Soheila Ghasemi; Mohsen Akbarian; Mojtaba Hoseini-Ghahfarokhi; Mohsen Moghoofei; Mohammad Doroudian
Journal:  Front Chem       Date:  2022-09-14       Impact factor: 5.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.